ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Study Sheds Light On How NSAIDS Prevent Colon Cancer

April 25, 2003

The Donald Pinkel Archive

May 21, 2021

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

NCI Seeks Changes In CIS Funding Plan With Next Recompetition

April 24, 1987

Stop Cancer Promises $7 Mil. By End Of Year

October 12, 1990